全球基因表現分析市場規模、佔有率、趨勢和成長分析報告（2026-2034）

基因表現分析市場預計將從 2025 年的 58.2 億美元成長到 2034 年的 146.8 億美元，2026 年至 2034 年的複合年成長率為 10.83%。

受基因組學進步和個人化醫療研發投入不斷增加的推動，全球基因表現分析市場正經歷快速成長。這項技術使科學家能夠研究基因活性並了解疾病機制，在癌症研究、藥物研發和診斷等領域中發揮著至關重要的作用。對精準醫療日益成長的關注也顯著提升了市場需求。

關鍵促進因素包括生物技術和藥物研發投入的增加，以及慢性病盛行率的上升。次世代定序（NGS）和微陣列等先進技術的引進，使得基因分析更精準有效率。此外，政府資助和研究舉措也推動了全球基因組學研究的擴展。

由於人工智慧和巨量資料分析的融合提高了基因表現研究的效率和準確性，該市場前景仍然強勁。基因分析在臨床診斷和標靶治療的應用不斷拓展，將進一步推動市場成長。隨著醫療保健持續向個人化治療模式轉變，預計該市場將顯著擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球基因表現分析市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 受託研究機構
• 其他

第5章 全球基因表現分析市場：依產品分類

• 市場分析、洞察與預測
• 消耗品
• 裝置

第6章 全球基因表現分析市場：依應用領域分類

• 市場分析、洞察與預測
• 藥物發現
• 診斷
• 研究

第7章 全球基因表現分析市場：依服務分類

• 市場分析、洞察與預測
• 基因表現分析服務
• 定序服務
• 生物資訊解決方案
• 其他

第8章 全球基因表現分析市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Illumina
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd
  • Pacific Biosciences Of California
  • BGI
  • PerkinElmer Inc
  • Agilent Technologies

The Gene Expression Analysis Market size is expected to reach USD 14.68 Billion in 2034 from USD 5.82 Billion (2025) growing at a CAGR of 10.83% during 2026-2034.

The global gene expression analysis market is witnessing rapid growth due to advancements in genomics and increasing research in personalized medicine. This technology allows scientists to study gene activity and understand disease mechanisms, making it crucial in areas such as cancer research, drug development, and diagnostics. The growing focus on precision healthcare is significantly boosting market demand.

Key drivers include rising investments in biotechnology and pharmaceutical research, along with increasing prevalence of chronic diseases. The adoption of advanced technologies such as next-generation sequencing (NGS) and microarrays is enabling more accurate and high-throughput gene analysis. Additionally, government funding and research initiatives are supporting the expansion of genomics-based studies worldwide.

Future prospects remain strong as the integration of artificial intelligence and big data analytics enhances the efficiency and accuracy of gene expression studies. The increasing application of gene analysis in clinical diagnostics and targeted therapies will further drive market growth. As healthcare continues to shift toward personalized treatment approaches, this market is expected to expand significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By End-User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations
• Others

By Product

• Consumables
• Instruments

By Application

• Drug Discovery
• Diagnosis
• Research

By Service

• Gene Expression Profiling Services
• Sequencing Services
• Bioinformatics Solutions
• Others

COMPANIES PROFILED

• General Electric Company, , Illumina, Thermo Fisher Scientific, BioRad Laboratories, F HoffmannLa Roche Ltd, Pacific Biosciences of California, BGI, PerkinElmer Inc, Agilent Technologies
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY END-USER 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast End-user
• 4.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY SERVICE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Service
• 7.2. Gene Expression Profiling Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Sequencing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Bioinformatics Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By End-user
  • 8.2.2 By Product
  • 8.2.3 By Application
  • 8.2.4 By Service
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By End-user
  • 8.3.2 By Product
  • 8.3.3 By Application
  • 8.3.4 By Service
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By End-user
  • 8.4.2 By Product
  • 8.4.3 By Application
  • 8.4.4 By Service
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By End-user
  • 8.5.2 By Product
  • 8.5.3 By Application
  • 8.5.4 By Service
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By End-user
  • 8.6.2 By Product
  • 8.6.3 By Application
  • 8.6.4 By Service
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENE EXPRESSION ANALYSIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Illumina
  • 10.2.2 Thermo Fisher Scientific
  • 10.2.3 Bio-Rad Laboratories
  • 10.2.4 F. Hoffmann-La Roche Ltd
  • 10.2.5 Pacific Biosciences Of California
  • 10.2.6 BGI
  • 10.2.7 PerkinElmer Inc
  • 10.2.8 Agilent Technologies